Peringatan Keamanan

Symptoms of overdose include nausea, vomiting, fatigue, urinary problems and drowsiness.

Benzthiazide

DB00562

small molecule approved

Deskripsi

Benzthiazide is used to treat hypertension and edema. Like other thiazides, benzthiazide promotes water loss from the body (diuretics). They inhibit Na+/Cl- reabsorption from the distal convoluted tubules in the kidneys. Thiazides also cause loss of potassium and an increase in serum uric acid. Thiazides are often used to treat hypertension, but their hypotensive effects are not necessarily due to their diuretic activity. Thiazides have been shown to prevent hypertension-related morbidity and mortality although the mechanism is not fully understood. Thiazides cause vasodilation by activating calcium-activated potassium channels (large conductance) in vascular smooth muscles and inhibiting various carbonic anhydrases in vascular tissue.

Struktur Molekul 2D

Berat 431.937
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Absorbed in the digestive tract.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

1427 Data
Forasartan Benzthiazide may increase the hypotensive and Electrolyte Disturbance activities of Forasartan.
Tasosartan Benzthiazide may increase the hypotensive and Electrolyte Disturbance activities of Tasosartan.
Saralasin Benzthiazide may increase the hypotensive and Electrolyte Disturbance activities of Saralasin.
Fimasartan Benzthiazide may increase the hypotensive and Electrolyte Disturbance activities of Fimasartan.
Nicotine The risk or severity of adverse effects can be increased when Benzthiazide is combined with Nicotine.
Cyclopentamine The risk or severity of adverse effects can be increased when Benzthiazide is combined with Cyclopentamine.
Allopurinol The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Benzthiazide.
Carbamazepine The risk or severity of adverse effects can be increased when Benzthiazide is combined with Carbamazepine.
Cyclophosphamide The risk or severity of granulocytopenia can be increased when Benzthiazide is combined with Cyclophosphamide.
Diazoxide The risk or severity of hypotension, hyperglycemia, and hyperuricemia can be increased when Benzthiazide is combined with Diazoxide.
Dofetilide The risk or severity of QTc prolongation can be increased when Benzthiazide is combined with Dofetilide.
Ivabradine The risk or severity of Cardiac Arrhythmia can be increased when Benzthiazide is combined with Ivabradine.
Lithium citrate Benzthiazide may decrease the excretion rate of Lithium citrate which could result in a higher serum level.
Lithium carbonate Benzthiazide may decrease the excretion rate of Lithium carbonate which could result in a higher serum level.
Lithium hydroxide Benzthiazide may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.
Oxcarbazepine The risk or severity of hyponatremia can be increased when Benzthiazide is combined with Oxcarbazepine.
Topiramate The risk or severity of hypokalemia can be increased when Benzthiazide is combined with Topiramate.
Toremifene The risk or severity of hypercalcemia can be increased when Benzthiazide is combined with Toremifene.
Methotrexate The protein binding of Methotrexate can be increased when combined with Benzthiazide.
Sulpiride The risk or severity of orthostatic hypotension can be increased when Benzthiazide is combined with Sulpiride.
Insulin human The risk or severity of hypoglycemia can be increased when Benzthiazide is combined with Insulin human.
Insulin lispro The risk or severity of hypoglycemia can be increased when Benzthiazide is combined with Insulin lispro.
Insulin glargine The risk or severity of hypoglycemia can be increased when Benzthiazide is combined with Insulin glargine.
Insulin pork The risk or severity of hypoglycemia can be increased when Benzthiazide is combined with Insulin pork.
Troglitazone The therapeutic efficacy of Troglitazone can be decreased when used in combination with Benzthiazide.
Glimepiride The therapeutic efficacy of Glimepiride can be decreased when used in combination with Benzthiazide.
Sulfisoxazole The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Benzthiazide.
Disopyramide The therapeutic efficacy of Disopyramide can be decreased when used in combination with Benzthiazide.
Acarbose The therapeutic efficacy of Acarbose can be decreased when used in combination with Benzthiazide.
Sulfadiazine The therapeutic efficacy of Sulfadiazine can be decreased when used in combination with Benzthiazide.
Rosiglitazone The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Benzthiazide.
Acetohexamide The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Benzthiazide.
Quinine The therapeutic efficacy of Quinine can be decreased when used in combination with Benzthiazide.
Miglitol The therapeutic efficacy of Miglitol can be decreased when used in combination with Benzthiazide.
Chlorpropamide The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Benzthiazide.
Nateglinide The therapeutic efficacy of Nateglinide can be decreased when used in combination with Benzthiazide.
Pentamidine The therapeutic efficacy of Pentamidine can be decreased when used in combination with Benzthiazide.
Mifepristone The therapeutic efficacy of Mifepristone can be decreased when used in combination with Benzthiazide.
Tolazamide The therapeutic efficacy of Tolazamide can be decreased when used in combination with Benzthiazide.
Repaglinide The therapeutic efficacy of Repaglinide can be decreased when used in combination with Benzthiazide.
Phenformin The therapeutic efficacy of Phenformin can be decreased when used in combination with Benzthiazide.
Sulfamethoxazole The therapeutic efficacy of Sulfamethoxazole can be decreased when used in combination with Benzthiazide.
Glyburide The therapeutic efficacy of Glyburide can be decreased when used in combination with Benzthiazide.
Glipizide The therapeutic efficacy of Glipizide can be decreased when used in combination with Benzthiazide.
Gliclazide The therapeutic efficacy of Gliclazide can be decreased when used in combination with Benzthiazide.
Tolbutamide The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Benzthiazide.
Pioglitazone The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Benzthiazide.
Bromocriptine The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Benzthiazide.
Gliquidone The therapeutic efficacy of Gliquidone can be decreased when used in combination with Benzthiazide.
Mitiglinide The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Benzthiazide.
Sitagliptin The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Benzthiazide.
Sunitinib The therapeutic efficacy of Sunitinib can be decreased when used in combination with Benzthiazide.
Exenatide The therapeutic efficacy of Exenatide can be decreased when used in combination with Benzthiazide.
Mecasermin The therapeutic efficacy of Mecasermin can be decreased when used in combination with Benzthiazide.
Pramlintide The therapeutic efficacy of Pramlintide can be decreased when used in combination with Benzthiazide.
Glisoxepide The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Benzthiazide.
Insulin aspart The risk or severity of hypoglycemia can be increased when Benzthiazide is combined with Insulin aspart.
Insulin detemir The risk or severity of hypoglycemia can be increased when Benzthiazide is combined with Insulin detemir.
Insulin glulisine The risk or severity of hypoglycemia can be increased when Benzthiazide is combined with Insulin glulisine.
Glymidine The therapeutic efficacy of Glymidine can be decreased when used in combination with Benzthiazide.
AICA ribonucleotide The therapeutic efficacy of AICA ribonucleotide can be decreased when used in combination with Benzthiazide.
Buformin The therapeutic efficacy of Buformin can be decreased when used in combination with Benzthiazide.
Vildagliptin The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Benzthiazide.
Voglibose The therapeutic efficacy of Voglibose can be decreased when used in combination with Benzthiazide.
NN344 The risk or severity of hypoglycemia can be increased when Benzthiazide is combined with NN344.
AMG-222 The therapeutic efficacy of AMG-222 can be decreased when used in combination with Benzthiazide.
Bisegliptin The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Benzthiazide.
Alogliptin The therapeutic efficacy of Alogliptin can be decreased when used in combination with Benzthiazide.
Dapagliflozin The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Benzthiazide.
Saxagliptin The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Benzthiazide.
Liraglutide The therapeutic efficacy of Liraglutide can be decreased when used in combination with Benzthiazide.
Gosogliptin The therapeutic efficacy of Gosogliptin can be decreased when used in combination with Benzthiazide.
Linagliptin The therapeutic efficacy of Linagliptin can be decreased when used in combination with Benzthiazide.
Canagliflozin The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Benzthiazide.
Glibornuride The therapeutic efficacy of Glibornuride can be decreased when used in combination with Benzthiazide.
Benfluorex The therapeutic efficacy of Benfluorex can be decreased when used in combination with Benzthiazide.
Albiglutide The therapeutic efficacy of Albiglutide can be decreased when used in combination with Benzthiazide.
Dulaglutide The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Benzthiazide.
Lobeglitazone The therapeutic efficacy of Lobeglitazone can be decreased when used in combination with Benzthiazide.
Netoglitazone The therapeutic efficacy of Netoglitazone can be decreased when used in combination with Benzthiazide.
Rivoglitazone The therapeutic efficacy of Rivoglitazone can be decreased when used in combination with Benzthiazide.
Ciglitazone The therapeutic efficacy of Ciglitazone can be decreased when used in combination with Benzthiazide.
Lixisenatide The therapeutic efficacy of Lixisenatide can be decreased when used in combination with Benzthiazide.
Insulin beef The risk or severity of hypoglycemia can be increased when Benzthiazide is combined with Insulin beef.
Insulin degludec The risk or severity of hypoglycemia can be increased when Benzthiazide is combined with Insulin degludec.
Insulin peglispro The risk or severity of hypoglycemia can be increased when Benzthiazide is combined with Insulin peglispro.
Insulin tregopil The risk or severity of hypoglycemia can be increased when Benzthiazide is combined with Insulin tregopil.
Ipragliflozin The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Benzthiazide.
Dutogliptin The therapeutic efficacy of Dutogliptin can be decreased when used in combination with Benzthiazide.
Allicin The therapeutic efficacy of Allicin can be decreased when used in combination with Benzthiazide.
Tofogliflozin The therapeutic efficacy of Tofogliflozin can be decreased when used in combination with Benzthiazide.
Ertugliflozin The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Benzthiazide.
2,4-thiazolidinedione The therapeutic efficacy of 2,4-thiazolidinedione can be decreased when used in combination with Benzthiazide.
Teneligliptin The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Benzthiazide.
Omarigliptin The therapeutic efficacy of Omarigliptin can be decreased when used in combination with Benzthiazide.
Carmegliptin The therapeutic efficacy of Carmegliptin can be decreased when used in combination with Benzthiazide.
Gemigliptin The therapeutic efficacy of Gemigliptin can be decreased when used in combination with Benzthiazide.
Anagliptin The therapeutic efficacy of Anagliptin can be decreased when used in combination with Benzthiazide.
Evogliptin The therapeutic efficacy of Evogliptin can be decreased when used in combination with Benzthiazide.
Sotagliflozin The therapeutic efficacy of Sotagliflozin can be decreased when used in combination with Benzthiazide.

Target Protein

Solute carrier family 12 member 3 SLC12A3
Carbonic anhydrase CA1
Carbonic anhydrase 2 CA2
Carbonic anhydrase 1 CA1
Carbonic anhydrase 4 CA4
Carbonic anhydrase 9 CA9
Carbonic anhydrase 12 CA12

Referensi & Sumber

Synthesis reference: Samuel M. Fainberg, Porfirio F. Perez, "Stable solution of benzthiazide (3-benzythiol methyl-6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide) suitable for parenteral administration and process of preparation." U.S. Patent US4022894, issued May 10, 1977.

Contoh Produk & Brand

Produk: 0 • International brands: 6
International Brands
  • Aquatag
  • Dihydrex
  • Diucen
  • Edemax
  • Exna
  • Foven

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul